Remedent Gross profit (Q2, 2018)481 K

Remedent Gross profit margin (Q2, 2018), %70.9%

Remedent EBIT (Q2, 2018)-46.2 K

Remedent Cash, 30-Sep-201788.8 K

USD | FY, 2014 | FY, 2015 | FY, 2016 |
---|---|---|---|

## Revenue | 2.6 m | 3.6 m | 2.8 m |

| 39% | (23%) | |

## Cost of goods sold | 965 k | 1.3 m | 817.4 k |

## Gross profit | 1.6 m | 2.3 m | 2 m |

| 63% | 65% | 70% |

## Sales and marketing expense | 682.7 k | 756.2 k | 493.8 k |

## R&D expense | 77.5 k | 61.2 k | 8.8 k |

## General and administrative expense | 1.4 m | 1.2 m | 1.3 m |

## Operating expense total | 2.1 m | 2 m | 1.8 m |

## EBIT | (737.3 k) | 105.4 k | 7.2 k |

| (28%) | 3% | 0% |

## Interest expense | 130 k | 75.1 k | 63.4 k |

## Interest income | 11.3 k | ||

## Income tax expense | 30.6 k | (22.9 k) | |

## Net Income | 524.5 k |

USD | FY, 2014 | FY, 2015 | FY, 2016 |
---|---|---|---|

## Cash | 775.3 k | 399.1 k | 94.4 k |

## Current Assets | 3.4 m | 2.9 m | 2.9 m |

## PP&E | 489.4 k | 435.3 k | 410.9 k |

## Total Assets | 6.2 m | 5.5 m | 5.7 m |

## Current Liabilities | 3.8 m | 3.4 m | 3.4 m |

## Long-term debt | 273.2 k | ||

## Additional Paid-in Capital | 24.9 m | 24.9 m | 24.9 m |

## Retained Earnings | (21.1 m) | (21 m) | (20.8 m) |

## Total Equity | 2.3 m | 2.1 m | 2.3 m |

## Financial Leverage | 2.7 x | 2.6 x | 2.5 x |

USD | FY, 2014 | FY, 2015 | FY, 2016 |
---|---|---|---|

## Net Income | 524.5 k | ||

## Depreciation and Amortization | 240 k | 254.8 k | 158.5 k |

## Cash From Operating Activities | (103.9 k) | 300.6 k | (203.1 k) |

## Cash From Investing Activities | (81.4 k) | (240.5 k) | (116.3 k) |

## Cash From Financing Activities | 1.2 m | (358.1 k) | |

## Interest Paid | 63 k | 25.1 k | 13.4 k |

USD | Y, 2017 |
---|---|

## Revenue/Employee | 42.4 k |

## Financial Leverage | 1.5 x |

Report incorrect company information